CAS: 16874-12-7; H-Tyr-Otbu

该化合物是氨酸L-tyrosine的酯衍生物,该化合物的外质为叔丁基酯,与母氨基酸相比,其脂性更加强.L-Tyrosine本身是一种非必要的氨基酸,在...

结构式图片

相似化合物

87553-74-0 18938-60-8 16881-33-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号16881-33-7 CBZ-L-酪氨酸叔丁酯 | CAS号1164-16-5 N-苄氧羰基-L-酪氨酸 | CAS号540-88-5 醋酸叔丁酯 | CAS号60-18-4 L-酪氨酸 | CAS号5544-60-5 4-苄氧基溴苄 | CAS号81477-94-3 二苯亚甲基甘氨酸叔丁酯 | CAS号115-11-7 2-甲基丙烯 | CAS号60-18-4 L-酪氨酸 | CAS号52434-75-0 LHRH (1-5) (FRE... | CAS号16881-33-7 CBZ-L-酪氨酸叔丁酯

合成工艺路线路线简述

    N-二苯亚甲基-甘氨酸叔丁酯置于palladium On Activated Charcoal 氢氧化钾,C2-Symmetric Chiral Quaternary Ammonium Salt,氢气,柠檬酸体系中,用 四氢呋喃,甲苯 用作溶剂,化学反应 15.0H,反应生成L-酪氨酸叔丁酯
    参考文献:用于实际催化不对称合成的新型手性相转移催化剂的设计
    标题:用于实际催化不对称合成的新型手性相转移催化剂的设计
    摘要:衍生自商业可获得的(S)-联萘酚的1型结构刚性手性螺环铵盐已被设计为一种新型的c 2对称手性相转移催化剂,已成功地用于甘氨酸叔丁酯的高效催化对映选择性烷基化schiff碱在温和的相转移条件下可提供具有出色对映选择性的α-烷基-α-氨基酸和α,α-二烷基-α-氨基酸.这些铵盐也已用于原位生成手性季铵氟化物.
    Doi:10.1016/s0022-1139(01)00472-9

    海关参考信息

    专利信息


    专利号:US-8268936-B2
    优先权日:2005-01-04
    标题:Synthesis of hybrid block copolymers and uses thereof
    发明人:BREITENKAMP KURT; SILL KEVIN N
    权利人:BREITENKAMP KURT; SILL KEVIN N; INTEZYNE TECHNOLOGIES INC
    摘要:The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and methods of preparing the same.

    专利号:US-2012196989-A1
    优先权日:2005-02-11
    标题:Synthesis of homopolymers and block copolymers
    发明人:BREITENKAMP KURT; SILL KEVIN N
    权利人:BREITENKAMP KURT; SILL KEVIN N; INTEZYNE TECHNOLOGIES INC
    摘要:The present invention relates to the field of polymer chemistry and more particularly to homopolymers and block copolymers and methods of preparing the same.

    专利号:US-8030496-B2
    优先权日:2005-02-17
    标 题:Intermediate compound for synthesis of viridiofungin a derivative
    发明人:KATO TATSUYA; KIMURA NOBUAKI; MIZUTANI AKEMI; MAKINO TOSHIHIKO; KAWASAKI KENICHI; FUKUDA HIROSHI; KOMIYAMA SUSUMU; TSUKUDA TAKUO
    权利人:CHUGAI PHARMACEUTICAL CO LTD
    摘要:A method whereby a compound having HCV replication inhibitory activity and desired optical activity can be synthesized selectively and at high yield in a small number of steps by using a compound having a specific chiral auxiliary as a starting compound is provided. n A compound represented by the formula (1-8): n n n n n n n n n n n n wherein Y represents a group represented by the following formula: n n n n n n n n n n n n n n n n Q represents a protected carbonyl group; D represents —(CH 2 ) m —R′, etc.; and n represents an integer of 0 to 10.

    专利号:US-5688992-A
    优先权日:1995-03-31
    标题 :O-malonyltryrosyl compounds, O-malonyltryrosyl compound-containing peptides, and use thereof
    发明人:BURKE JR TERRENCE R; YE BIN; AKAMATSU MIKI; KOLE HEMANTA K; YAN XINJIAN; ROLLER PETER R
    权利人:US HEALTH
    摘要:The present invention relates to non-phosphorus containing O-malonyltryrosyl compounds, derivatives thereof, uses of the O-malonyltryrosyl compounds in the synthesis of peptides, and O-malonyltryrosyl compound-containing peptides. The O-malonyltyrosyl malonyltyrosyl compounds and O-malonyltryrosyl compound-containing peptides of the present invention are uniquely stable to phosphotases, capable of crossing cell membranes, suitable for application to peptide synthesis of O-malonyltryrosyl compound-containing peptides, and amenable to prodrag defivatization for delivery into cells. The present invention also provides for O-malonyltryrosyl compound-containing peptides which exhibit inhibitory potency against binding interactions of receptor domains with phosphotyrosyl-containing peptide ligands.

    专利号:WO-2019241903-A1
    优先权日:2018-06-19
    标 题 :Synthetic method of bivalirundin
    发明人:BONAVENTURA IVAN DI; HE RUNZE
    权利人:SHANGHAI SPACE PEPTIDES PHARMACEUTICAL CO LTD
    摘要:The Active Pharmaceutical Ingredient (API), Bivalirudin, is a 20 amino acid peptide containing one basic and 5 amino acid residues. With a chemical formula of C98H138N24O33 and a molecular weight of 2180.3 g/mol. Bivalirudin is also known as Angiomax. It is a direct thrombin inhibitor indicated for use as an anticoagulant. It provides a method for synthesizing bivalirudin and in particular to the synthetic method of bivalirudin by solid phase peptide synthesis using Fmoc-Leu-Wang resin as a carrier. The method has the advantages of high yield, less by-product and simple separation and purification, and it's time gaining than the prior art, and is suitable for pilot and industrial production.

    专利号:US-2006172914-A1
    优先权日:2005-01-04
    标题:Synthesis of hybrid block copolymers and uses thereof
    杭州凯邦生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemspon.com
    企业联系电话:0571-88937695👤
    📞杭州凯邦生物科技有限公司 ⚠️参考联系方式
    联系人:项经理
    电话:0571-88937695
    手机:13606537248
    传真:0571-88933015
    邮箱:sales@chemspon.com
    通信地址: 浙江省杭州市拱墅区祥园路39号
    邮编: 310015
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市拱墅区祥园路39号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Luckose F, Et Al. Effects Of Amino Acid Derivatives On Physical, Mental, And Physiological Activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

    合成参考文献


    摘要:Lubell, W. D.; Blankenship, J. W.; Fridkin, G.; Kaul, R., Science of Synthesis, (2005) 21, 722.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知